-
公开(公告)号:DE3331399A1
公开(公告)日:1985-03-07
申请号:DE3331399
申请日:1983-08-31
Applicant: BASF AG
Inventor: FISCHER ROLF DR , WEITZ HANS-MARTIN DR , SCHMIEDER KLAUS DR , PAUST JOACHIM DR
IPC: C07C67/00 , C07C67/29 , C07C67/343 , C07C69/16 , C07C69/63 , C07C69/732 , C07C69/635
-
公开(公告)号:DE2961892D1
公开(公告)日:1982-03-04
申请号:DE2961892
申请日:1979-09-28
Applicant: BASF AG
Inventor: PAUST JOACHIM DR , NUERRENBACH AXEL DR
IPC: A61K31/165 , A61K31/13 , A61P35/00 , C07C67/00 , C07C401/00 , C07C403/00 , C07C403/18 , C07D209/48 , C07C175/00
-
公开(公告)号:DE2960041D1
公开(公告)日:1981-02-05
申请号:DE2960041
申请日:1979-02-19
Applicant: BASF AG
Inventor: PAUST JOACHIM DR , SCHMIDT WOLFRAM DR
IPC: C07D307/32 , C07D307/33
Abstract: Pantolactone is extracted from its aqueous solutions using methyl tert.-butyl ether as the extractant.
-
公开(公告)号:DE2300107A1
公开(公告)日:1974-07-11
申请号:DE2300107
申请日:1973-01-03
Applicant: BASF AG
Inventor: KOENIG HORST DR , PEH JUTTA DR MED , SCHOLZ HERBERT DR , PAUST JOACHIM DR
IPC: A61K31/16 , A61K31/245 , C07C403/00 , C07D295/16 , C07D295/185 , C07C175/00 , C07D29/20 , C07D87/34
-
公开(公告)号:ES2209735T3
公开(公告)日:2004-07-01
申请号:ES00118466
申请日:2000-08-25
Applicant: BASF AG
Inventor: WEGNER CHRISTOPH DR , PAUST JOACHIM DR , ERNST HANSGEORG DR
-
公开(公告)号:ES2209290T3
公开(公告)日:2004-06-16
申请号:ES99113420
申请日:1999-07-12
Applicant: BASF AG
Inventor: AUWETER HELMUT DR , BOHN HERIBERT , HORN DIETER DR , KRAMER KLAUS DR , PAUST JOACHIM DR , WEISS HORST DR
IPC: A23K1/16 , A23L1/275 , A23L5/41 , A23L5/44 , A61K8/31 , A61K8/35 , A61K8/46 , A61K8/49 , A61K8/60 , A61K31/395 , A61K31/52 , A61Q19/00 , C07C403/00 , C07C403/24 , C07D339/04 , C09B61/00 , C09B67/42 , A23L1/272
Abstract: The use of organosulfur compounds is claimed for bathochromic shifting of the UV/visible absorption spectrum of carotinoids. Independent claims are included for: (A) complexes comprising one or more organosulfur compounds and one or more carotinoids, and (B) preparation of carotinoid formulations, which comprises dispersion of an organosulfur/carotinoid mixture in water or a protective colloid solution, followed by drying of the dispersion.
-
公开(公告)号:AT229495T
公开(公告)日:2002-12-15
申请号:AT00115618
申请日:2000-07-20
Applicant: BASF AG
Inventor: PAUST JOACHIM DR , ERNST HANSGEORG DR , KACZMAREK REINHARD DR , JAEDICKE HAGEN DR
IPC: C07B61/00 , C07C231/08 , C07C233/18 , C07C233/47 , C07C233/69 , C07C233/83
Abstract: Preparation of N-acyl derivatives (I) using readily available starting materials. N-acyl derivatives of formula R -C(O)N(H)C(R )X (I) are prepared by reacting, in the presence of a compound of formula R -COOH (II), a carbonic acid amide of formula R -CONH2 (III) and a glyoxalmonoacetal derivative of formula R C(O)C(OR )OR (IV). R , R = H or optionally substituted alkyl or aryl; R ,R = 1 - 12C alkyl; and X = CH(OR ) or COOR . An Independent claim is also included for a compound of formula R -C(O)N(H)C(R )C(OR )OR (V).
-
公开(公告)号:DE19723480A1
公开(公告)日:1998-12-10
申请号:DE19723480
申请日:1997-06-04
Applicant: BASF AG
Inventor: PAUST JOACHIM DR , KRIEGL WOLFGANG
IPC: C07C403/24 , C07D493/08 , C07F9/50 , C07F9/54
Abstract: Preparation of (3R,3'R)-zeaxanthin (I) comprises: (i) reacting (4R)-4-hydroxy-2,2,6-trimethyl-cyclohexanone (II) with dichloromethyl lithium in an inert solvent at -120 to -40 degrees C and warming the reaction mixture to 20-60 degrees C; (ii) reacting the obtained (4R,6R)-1-formyl-2,2,6-trimethyl-7-oxa-bicyclo (2.2.1) heptane of formula (IV) (in isolated form or directly in the reaction mixture) with acetone or a dialkyl (2-oxo-propyl)-phosphonate; (iii) converting the obtained (4R,6R)-1-(3-oxo-but-1-en-1-yl)-2,2,6-trimethyl-7-oxa-bicyclo (2.2.1) heptane of formula (V) into (4R,6R)-1-(3-hydroxy-3-methylpenta-1,4-dienyl)-2,2,6-trimethyl-7-oxa-b icyclo (2.2.1) heptane (VI) by conventional vinylation (or ethynylation followed by partial hydrogenation); (iv) reacting (VI) with a triaryl phosphine (preferably PPh3) and a strong acid to give a mixture of a C15 triaryl phosphonium salt of formula (III) and the isomer of formula (III'); and (v) subjecting 2 moles of the mixture to a double Wittig olefin synthesis reaction with 2,7-dimethyl-octa-2,4,6-triene-1,8-dial (VIII) to give (I). Ar = aryl (preferably optionally substituted phenyl); and X = 1 equivalent of an anion of a strong acid (preferably Cl, Br or HSO4). The preparation of (I) by step (v) is claimed per se. Also claimed are (IV) and (V) and (III') in mixtures with (III).
-
公开(公告)号:ES2114984T3
公开(公告)日:1998-06-16
申请号:ES93113731
申请日:1993-08-27
Applicant: BASF AG
Inventor: PAUST JOACHIM DR , ECKES PETER DR , SIEGEL WOLFGANG DR , BALKENHOHL FRIEDHELM DR , DOBLER WALTER DR , HULLMANN MICHAEL DR
IPC: C07C323/52 , C07C67/00 , C07C69/06 , C07C69/708 , C07C319/08 , C07D339/04
-
公开(公告)号:ES2101906T3
公开(公告)日:1997-07-16
申请号:ES93112314
申请日:1993-07-31
Applicant: BASF AG
Inventor: KAISER KLAUS DR , BALKENHOHL FRIEDHELM DR , PAUST JOACHIM DR
IPC: C07F9/655
Abstract: Process for obtaining the calcium salt of ascorbyl 2-monophosphate from aqueous/alkaline reaction mixtures as they are obtained when ascorbic acid is reacted with a molar excess of phosphorus oxychloride in the presence of a tertiary amine while maintaining a pH of 12 to 13 during the reaction by means of an aqueous alkali metal solution, which process is characterised in that a) starting from a reaction mixture which has been obtained by reacting ascorbic acid with phosphorus oxychloride in the presence of pyridine while maintaining a pH of 12 to 13 by means of an aqueous potassium hydroxide solution, b) the phosphoric acid ions formed during this reaction are precipitated by means of magnesium chloride in amounts of approximately 1 mol per mol of phosphoric acid ions as potassium magnesium phosphate, c) the potassium magnesium phosphate is separated off, d) the pyridine together with some of the water is removed from the remaining aqueous solution by distillation, e) the resulting aqueous solution is reacted with calcium chloride and f) the calcium salt of ascorbyl 2-monophosphate, which crystallises out during this process in the form of the calcium salt, is isolated, or in that, after process step a), the pyridine/water mixture is first removed as described in process step d) and process steps (b), (c), (e) and (f) are subsequently carried out.
-
-
-
-
-
-
-
-
-